Research Article
Development and Characterization of Novel Floating-Mucoadhesive Tablets Bearing Venlafaxine Hydrochloride
Table 1
Formulation for optimization of drug: HPMC K4MCR ratio.
| Ingredients (in mg) | Formulation code (FC) | FC1 | FC2 | FC3 | FC4 |
| Venlafaxine hydrochloride | 42.43 | 42.43 | 42.43 | 42.43 | HPMC K4MCR | 130 | 135 | 140 | 145 | Carbopol 934PNF | 15 | 15 | 15 | 15 | Sodium bicarbonate | 15 | 15 | 15 | 15 | Lactose | 30 | 30 | 30 | 30 | Magnesium stearate | 2.57 | 2.57 | 2.57 | 2.57 | Tablet Wt. (mg) | 235 | 240 | 245 | 250 |
|
|